PharmaMar signs licensing agreement with Eczacıbasi Group for Aplidin
PharmaMar has signed agreement with Eczacibasi Group to commercialize the marine-derived anticancer drug Aplidin (plitidepsin) in Turkey. Aplidin is PharmaMar´s second most advanced…
Read More...
Read More...